BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 8, 2015
app pub date -
Nov 5, 2013
filing date -
Nov 5, 2012
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to a method for the prognosis of Symptomatic Multiple Myeloma (MM) and/or to monitor the response and/or the efficacy of a MM therapy comprising detecting and/or quantifying at least one marker, to relative kit and uses thereof and to relative microarray and use thereof. Markers include C3f peptide or a fragment thereof and/or other metabolites.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully